BRAF and melanoma: ADA also inhibited the proliferation of all the other human melanoma cell lines employed in this study, namely SK-Mel-5, SK-Mel-28, WM983A, and PES43 cell lines, all carrying the BRAFv600E mutation and the WM3060 cell line wild type for BRAF, without affecting NHEM proliferation (Table 1).